We are live on ! Find out more
RKDA icon

Arcadia Biosciences
RKDA

28 hedge funds and large institutions have $640K invested in Arcadia Biosciences in 2022 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 12 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 3

17% more funds holding

Funds holding: 24 → 28 (+4)

3.72% less ownership

Funds ownership: 13.33% → 9.61% (-3.7%)

58% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 12

63% less capital invested

Capital invested by funds: $1.73M → $640K (-$1.09M)

Holders
28
Holders Change
+4
Holders Change %
+16.67%
% of All Funds
0.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
5
Reduced
12
Closed
3
Calls
$3K
Puts
–
Net Calls
+$3K
Net Calls Change
-$4K

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$64.6K
2
Millennium Management
Millennium Management
New York
+$53.9K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$46.2K
4
HF
HRT Financial
New York
+$29.6K
5
E
Ergoteles
New York
+$16.6K

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$382K
2
Vanguard Group
Vanguard Group
Pennsylvania
-$158K
3
TSS
Two Sigma Securities
New York
-$10.7K
4
UBS Group
UBS Group
Switzerland
-$8K
5
Wells Fargo
Wells Fargo
California
-$6.75K

RKDA Hedge Fund Activity: Q4 2022 in Review

28 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Arcadia Biosciences (RKDA) for Q4 2022, worth a combined $640K — down 63% from $1.73M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new RKDA positions and 3 closed out — a net gain of 4 holders — while 5 added to existing stakes and 12 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $64.6K. The largest seller was Armistice Capital, cutting an estimated $382K.

  • 28 institutional investors held Arcadia Biosciences (RKDA) as of Q4 2022, up from 24 in Q3 2022.
  • Funds reported $640K of Arcadia Biosciences stock for Q4 2022, down 63% quarter-over-quarter.
  • 7 funds opened new Arcadia Biosciences positions in Q4 2022 and 3 closed out, a net change of +4 holders.
  • The largest Arcadia Biosciences buyer in Q4 2022 was Citadel Advisors, an estimated $64.6K added.
  • The largest Arcadia Biosciences seller in Q4 2022 was Armistice Capital, an estimated $382K sold.

Based on aggregated 13F filings for Q4 2022.